Citi Downgrades Zoetis, Cites Valuation

By: via Benzinga
Zoetis Inc (NYSE: ZTS) has been meaningfully outperforming specialty pharma peers year-to-date. Citi’s Liav Abraham downgraded ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.